Marinus Pharmaceuticals (MRNS)
(Delayed Data from NSDQ)
$1.41 USD
-0.03 (-2.08%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $1.38 -0.03 (-2.13%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.68 | 0.74% |
Earnings Summary
For their last quarter, Marinus Pharmaceuticals (MRNS) reported earnings of -$0.74 per share, missing the Zacks Consensus Estimate of -$0.64 per share. This reflects a negative earnings surprise of 15.63%. Look out for MRNS's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.68 per share, reflecting a year-over-year decrease of 1.49%.
Earnings History
Price & Consensus
Zacks News for MRNS
Do Options Traders Know Something About Marinus (MRNS) Stock We Don't?
MRNS: What are Zacks experts saying now?
Zacks Private Portfolio Services